Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
June 4, 2019
Patent Application Number
15564694
Date Filed
May 5, 2016
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present application relates to conjugates comprising interleukin 2 (IL2), and a tumour necrosis factor, such as tumour necrosis factor alpha (TNFα), and an antibody molecule. The antibody molecule preferably binds to an antigen associated with neoplastic growth and/or angiogenesis, such as the Extra-Domain A (EDA) of fibronectin. The conjugate may be used in the treatment of cancer.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
